2024 Q3 Form 10-Q Financial Statement
#000149315224032170 Filed on August 14, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
Revenue | ||
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | ||
YoY Change | ||
Operating Profit | -$8.981M | -$1.462M |
YoY Change | 2923.89% | 367.09% |
Interest Expense | ||
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | -$1.111M | -$713.0K |
YoY Change | -495.5% | -136.3% |
Pretax Income | ||
YoY Change | ||
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$10.09M | -$2.175M |
YoY Change | -2687.77% | -202.5% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | -$0.22 | |
Diluted Earnings Per Share | -$0.22 | |
COMMON SHARES | ||
Basic Shares Outstanding | 47.70M shares | |
Diluted Shares Outstanding | 45.17M shares |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | ||
YoY Change | ||
Cash & Equivalents | $1.587M | |
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $3.307M | $405.0K |
YoY Change | 4033.82% | 173.65% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $14.83K | |
YoY Change | -99.7% | |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $2.070M | $1.531M |
YoY Change | -95.14% | -96.35% |
TOTAL ASSETS | ||
Total Short-Term Assets | $3.307M | $405.0K |
Total Long-Term Assets | $2.070M | $1.531M |
Total Assets | $5.377M | $1.936M |
YoY Change | -87.41% | -95.4% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $6.494M | $1.937M |
YoY Change | 162254.13% | 12813.33% |
Accrued Expenses | $5.730M | |
YoY Change | 461.21% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $383.8K | |
YoY Change | -85.03% | |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $11.01M | $11.79M |
YoY Change | 191.7% | 263.45% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | ||
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | ||
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $11.01M | $11.79M |
Total Long-Term Liabilities | ||
Total Liabilities | $18.68M | $24.20M |
YoY Change | 29.85% | 71.17% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$43.05M | -$23.80M |
YoY Change | 200.89% | 70.08% |
Common Stock | $4.573K | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$13.30M | -$23.80M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $5.377M | $1.936M |
YoY Change | -87.41% | -95.4% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$10.09M | -$2.175M |
YoY Change | -2687.77% | -202.5% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | ||
YoY Change | ||
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | ||
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | ||
Cash From Investing Activities | ||
Cash From Financing Activities | ||
Net Change In Cash | ||
YoY Change | ||
FREE CASH FLOW | ||
Cash From Operating Activities | ||
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
usd | |
CY2024Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2024Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
usd | |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
usd | |
CY2024Q2 | us-gaap |
Revenues
Revenues
|
usd | |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
usd | |
us-gaap |
Revenues
Revenues
|
usd | ||
us-gaap |
Revenues
Revenues
|
usd | ||
CY2024Q2 | SDST |
Settlement And Release Of Liabilities1
SettlementAndReleaseOfLiabilities1
|
usd | |
CY2023Q2 | SDST |
Settlement And Release Of Liabilities1
SettlementAndReleaseOfLiabilities1
|
usd | |
SDST |
Settlement And Release Of Liabilities1
SettlementAndReleaseOfLiabilities1
|
usd | ||
CY2024Q2 | SDST |
Write Off Contingent Warrants Associated With Shares Redeemed
WriteOffContingentWarrantsAssociatedWithSharesRedeemed
|
usd | |
CY2023Q2 | SDST |
Write Off Contingent Warrants Associated With Shares Redeemed
WriteOffContingentWarrantsAssociatedWithSharesRedeemed
|
usd | |
SDST |
Write Off Contingent Warrants Associated With Shares Redeemed
WriteOffContingentWarrantsAssociatedWithSharesRedeemed
|
usd | ||
CY2024Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | |
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | ||
SDST |
Cash Deposited In Trust Account
CashDepositedInTrustAccount
|
usd | ||
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
usd | ||
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
usd | |
CY2024Q2 | us-gaap |
Assets Current
AssetsCurrent
|
405000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
36000 | usd |
CY2024Q2 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
1531000 | usd |
CY2023Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
43704000 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
1936000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
43740000 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1937000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
64000 | usd |
CY2024Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
5730000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4327000 | usd |
CY2024Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11794000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7872000 | usd |
CY2024Q2 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
1906000 | usd |
CY2023Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
337000 | usd |
CY2024Q2 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
10500000 | usd |
CY2023Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
10500000 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
24200000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
18709000 | usd |
CY2024Q2 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
1531000 | usd |
CY2023Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
43704000 | usd |
CY2024Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-23796000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-18674000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-23795000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-18673000 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1936000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
43740000 | usd |
CY2024Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1462000 | usd |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
313000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3553000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1391000 | usd | |
SDST |
Settlement And Release Of Liabilities1
SettlementAndReleaseOfLiabilities1
|
2961000 | usd | |
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1462000 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-313000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3553000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1570000 | usd | |
CY2024Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
215000 | usd |
CY2023Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
471000 | usd |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
488000 | usd | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1392000 | usd | |
SDST |
Write Off Contingent Warrants Associated With Shares Redeemed
WriteOffContingentWarrantsAssociatedWithSharesRedeemed
|
130000 | usd | |
CY2024Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
928000 | usd |
CY2023Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1964000 | usd |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
1569000 | usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
56000 | usd | |
CY2023Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2435000 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1081000 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1466000 | usd | |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2122000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4634000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
3036000 | usd | |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-21405000 | usd |
CY2024Q2 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
-215000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-23795000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-18673000 | usd |
us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
-488000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4634000 | usd | |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-23795000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-15191000 | usd |
CY2023Q2 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
-921000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2122000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13990000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14734000 | usd |
us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
-2292000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
3036000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
3036000 | usd | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13990000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13990000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4634000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
3036000 | usd | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
488000 | usd | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1392000 | usd | |
SDST |
Fair Value Adjustment Of Warrants Write Off Of Contingent Warrant
FairValueAdjustmentOfWarrantsWriteOffOfContingentWarrant
|
1569000 | usd | |
SDST |
Fair Value Adjustment Of Warrants Write Off Of Contingent Warrant
FairValueAdjustmentOfWarrantsWriteOffOfContingentWarrant
|
-74000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
391000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
134000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1873000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-60000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1403000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-1995000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-668000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-619000 | usd | |
SDST |
Cash Deposited In Trust Account
CashDepositedInTrustAccount
|
900000 | usd | |
SDST |
Cash Withdrawn From Trust Account To Pay Redemptions
CashWithdrawnFromTrustAccountToPayRedemptions
|
42661000 | usd | |
SDST |
Cash Withdrawn From Trust Account To Pay Redemptions
CashWithdrawnFromTrustAccountToPayRedemptions
|
265050000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
42661000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
264150000 | usd | |
SDST |
Redemption Of Common Shares
RedemptionOfCommonShares
|
3797169 | shares | |
SDST |
Redemption Of Common Shares
RedemptionOfCommonShares
|
26068281 | shares | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
42661000 | usd | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
265050000 | usd | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
30000 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
646000 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1454000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-42015000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-263626000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-22000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-95000 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
22000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
101000 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6000 | usd |
us-gaap |
Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
|
447500000 | usd | |
us-gaap |
Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
|
50000000 | usd | |
CY2024Q2 | SDST |
Maximum Net Interest To Pay Dissolution Expenses
MaximumNetInterestToPayDissolutionExpenses
|
100000 | usd |
CY2024Q2 | SDST |
Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteABusinessCombination
|
1 | pure |
SDST |
Payments For Investment Of Cash In Trust Account
PaymentsForInvestmentOfCashInTrustAccount
|
150000 | usd | |
us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
1800000 | usd | |
SDST |
Minimum Net Tangible Assets Consummation Of Business Combination
MinimumNetTangibleAssetsConsummationOfBusinessCombination
|
5000001 | usd | |
SDST |
Aggregate Shares
AggregateShares
|
127777 | shares | |
SDST |
Shares Subject To Forfeiture
SharesSubjectToForfeiture
|
127777 | shares | |
CY2024Q2 | us-gaap |
Cash
Cash
|
0 | usd |
CY2024Q2 | SDST |
Working Capital Deficit
WorkingCapitalDeficit
|
11389000 | usd |
CY2024Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
10557453 | shares |
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
11221954 | shares |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zSKHeVrGarm6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_z5MVlbfFVEQ1">Concentration of Credit Risk</span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company can have significant cash balances at financial institutions which throughout the year may exceed the federally insured limit of $<span id="xdx_90E_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_c20240101__20240630_zQQOlzNdZnNg" title="Federal deposit insurance corporation premium expense">250,000</span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
250000 | usd | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_848_eus-gaap--UseOfEstimates_zKuP6N6V3kWe" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zugJ6uPOfXK9">Use of Estimates</span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated balance sheet and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2024Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
17054000 | usd |
SDST |
Underwriters Discount
UnderwritersDiscount
|
16500000 | usd | |
us-gaap |
Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
|
16254000 | usd | |
us-gaap |
Other Expenses
OtherExpenses
|
800000 | usd | |
CY2021Q1 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.00 | |
CY2021Q1 | SDST |
Class Of Warrant Or Right Exercisable Entity May Redeem Redemption Written Notice Period
ClassOfWarrantOrRightExercisableEntityMayRedeemRedemptionWrittenNoticePeriod
|
P30D | |
CY2021Q1 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
SDST |
Class Of Warrant Or Right Exercisable Entity May Redeem Redemption Price Per Warrant
ClassOfWarrantOrRightExercisableEntityMayRedeemRedemptionPricePerWarrant
|
0.01 | pure | |
SDST |
Underwriting Discount Percentage
UnderwritingDiscountPercentage
|
0.020 | pure | |
us-gaap |
Other Underwriting Expense
OtherUnderwritingExpense
|
6000000 | usd | |
SDST |
Deferred Underwriting Percentage
DeferredUnderwritingPercentage
|
0.035 | pure | |
CY2024Q2 | SDST |
Underwriter Cash Discount
UnderwriterCashDiscount
|
10500000 | usd |
CY2024Q2 | SDST |
Underwriter Cash Discount
UnderwriterCashDiscount
|
10500000 | usd |
CY2023Q1 | us-gaap |
Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
|
265050166 | usd |
CY2023Q1 | SDST |
Write Off Contingent Warrants Associated With Shares Redeemed
WriteOffContingentWarrantsAssociatedWithSharesRedeemed
|
130000 | usd |
SDST |
Founder Share Vesting Description
FounderShareVestingDescription
|
Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then 12.5% on each of the attainment of Return to Shareholders (as defined in the agreement) exceeding 20%, 30%, 40% and 50%. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. | ||
SDST |
Number Of Trading Days
NumberOfTradingDays
|
P20D | ||
SDST |
Number Of Trading Days Commencing
NumberOfTradingDaysCommencing
|
P30D | ||
SDST |
Number Of Trading Days Business Combination
NumberOfTradingDaysBusinessCombination
|
P150D | ||
CY2020Q4 | SDST |
Aggregate Loan Amount
AggregateLoanAmount
|
300000 | usd |
CY2020Q4 | us-gaap |
Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
|
1000 | usd |
us-gaap |
Sponsor Fees
SponsorFees
|
25000 | usd | |
CY2024Q2 | SDST |
General And Administrative Expenses Writeoff
GeneralAndAdministrativeExpensesWriteoff
|
350000 | usd |
SDST |
General And Administrative Expenses Writeoff
GeneralAndAdministrativeExpensesWriteoff
|
275000 | usd | |
CY2023Q2 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
75000 | usd |
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
150000 | usd | |
CY2024Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
10557453 | shares |
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
11221954 | shares |
SDST |
Number Of Warrants Issued
NumberOfWarrantsIssued
|
4977576 | shares | |
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
300000000 | usd | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
|
The Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then an additional 12.5% on the attainment of each of a series of certain “shareholder return” targets exceeding 20%, 30%, 40% and 50%, as further defined in the agreement. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. | ||
CY2024Q2 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
134550 | shares |
CY2023Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
3931719 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |